PAFAH Antibodies

Santa Cruz Biotechnology features a diverse variety of PAFAH monoclonal antibodies for investigating phospholipase A2 in various biological processes. PAFAH monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phospholipase A2 (PAFAH) plays a crucial role in lipid metabolism and inflammatory responses, making it an important target for studying various diseases, including cardiovascular disorders and cancer. By modulating the release of fatty acids and lysolipids, PAFAH influences cell signaling pathways and membrane dynamics, which are vital for maintaining cellular homeostasis. Understanding PAFAH function can provide insights into therapeutic strategies for managing inflammation and other related conditions. PAFAH monoclonal antibodies enable precise detection and characterization of PAFAH expression patterns across different tissue types and experimental conditions. Researchers worldwide rely on PAFAH monoclonal antibodies to explore cellular mechanisms and pathways involved in disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of PAFAH's role in human health and disease development.